We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Figure 1

Figure 1. From: Tumor Necrosis Factor Alpha Inhibitor Therapy and Cancer Risk In Chronic Immune Mediated Diseases.

Kaplan-Meier curves for patients with rheumatoid arthritis (RA), comparing rates of solid cancers in the tumor necrosis factor inhibitor(TNF-I)–treated group with rates of solid cancers in the comparator-treated group.A, Results from the primary analysis. B, Results from thesecondary analysis. The primary analysis examined only outcomes that occurred while patients were receiving therapy, and the secondary analysisallowed for an indefinite lag between discontinuation of therapy and the onset of cancer (see Patients and Methods). The Kaplan-Meier curves didnot suggest an increasing relative risk with longer followup time.

Kevin Haynes, et al. Arthritis Rheum. 2013 January;65(1):10.1002/art.37740.

Supplemental Content

Filter your results:

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk